Screener
NeoGenomics NEO Operating Income
Operating Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by NeoGenomics in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: NeoGenomics’s 10-Q, filed July 28, 2026.
- Filed
- Jul 28, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001077183-26-000059
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Sales and marketing | 27,275 | 24,075 | 51,105 | 46,758 |
| Impairment charges (Note 5) | — | 20,041 | — | 20,041 |
| Total operating expenses | 101,649 | 124,886 | 200,754 | 225,957 |
| LOSS FROM OPERATIONS | (9,771) | (47,628) | (28,012) | (75,453) |
| Interest income | 1,214 | 2,263 | 2,487 | 5,984 |
| Interest expense | (781) | (933) | (1,379) | (2,551) |
| Other (expense) income, net | (17) | 482 | (29) | 547 |
| Gain on extinguishment of debt (Note 6) | 11,181 | — | 11,181 | — |
Item 1. Financial Statements (unaudited)
FAQ
- What is NeoGenomics's operating income?
- NeoGenomics (NEO) reported operating income of -$9.77M in Q2 2026.
- How has NeoGenomics's operating income changed year-over-year?
- NeoGenomics's operating income increased by 79.5% year-over-year, from -$47.63M to -$9.77M.
- What is the long-term trend for NeoGenomics's operating income?
- Over 4 years (2021 to 2025), NeoGenomics's operating income has grown at a -0.6% compound annual growth rate (CAGR), from -$118.75M to -$115.88M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.
Ask your AI about NeoGenomics's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude